Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313404860> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4313404860 endingPage "50.01" @default.
- W4313404860 startingPage "50.01" @default.
- W4313404860 abstract "Abstract Adjuvants are crucial components of subunit vaccines, as they help induce immune responses to poorly immunogenic antigens. Merck has developed a variety of lipid nanoparticles (LNPs) that contain different cationic lipids, a critical component that is mainly responsible for the reactogenicity induced by the LNP. LNP A that incorporates cationic lipid A results in high antigen expression, robust antigen-specific humoral and cellular responses, and some dose dependent reactogenicity when combined with subunit proteins. In contrast, LNP B, which incorporates cationic lipid B which has a shorter half-life than cationic lipid A, results in high antigen expression, slightly lower immunogenicity, and improved tolerability. Previous studies have shown that mouse TLR2 may be involved in the mechanism of action of LNP A. To determine the human innate signaling pathways triggered by LNP A or LNP B, we stimulated human TLR-expressing HEK-Blue cell lines (Invivogen) with the LNPs followed by measuring SEAP activity. We did not see any activation of the human TLRs despite stimulating with high amounts of LNP. Next, we evaluated whether these LNPs generated different cytokine/chemokine profiles, indicative of differential cellular recruitment in BALB/c mice in vivo. We found that LNP A stimulation results in significant upregulation of monocyte and neutrophil-specific cytokines in the serum and quadricep muscle injection site, while LNP B leads to a lower response. Furthermore, we plan to investigate the recruitment of cells at the injection site and draining LNs by flow cytometry and imaging. Together, these experiments will help mechanistically determine how these fundamentally different LNPs can activate innate immune responses. Supported by Merck & Co." @default.
- W4313404860 created "2023-01-06" @default.
- W4313404860 creator A5005980025 @default.
- W4313404860 creator A5018338879 @default.
- W4313404860 creator A5032496186 @default.
- W4313404860 creator A5035342394 @default.
- W4313404860 creator A5040223083 @default.
- W4313404860 creator A5045132347 @default.
- W4313404860 creator A5045410009 @default.
- W4313404860 creator A5049228092 @default.
- W4313404860 creator A5056955604 @default.
- W4313404860 creator A5057849939 @default.
- W4313404860 creator A5076121567 @default.
- W4313404860 date "2022-05-01" @default.
- W4313404860 modified "2023-09-23" @default.
- W4313404860 title "Elucidating the Immunogenic Mechanisms of Merck’s Lipid Nanoparticle (LNP) Adjuvants" @default.
- W4313404860 doi "https://doi.org/10.4049/jimmunol.208.supp.50.01" @default.
- W4313404860 hasPublicationYear "2022" @default.
- W4313404860 type Work @default.
- W4313404860 citedByCount "0" @default.
- W4313404860 crossrefType "journal-article" @default.
- W4313404860 hasAuthorship W4313404860A5005980025 @default.
- W4313404860 hasAuthorship W4313404860A5018338879 @default.
- W4313404860 hasAuthorship W4313404860A5032496186 @default.
- W4313404860 hasAuthorship W4313404860A5035342394 @default.
- W4313404860 hasAuthorship W4313404860A5040223083 @default.
- W4313404860 hasAuthorship W4313404860A5045132347 @default.
- W4313404860 hasAuthorship W4313404860A5045410009 @default.
- W4313404860 hasAuthorship W4313404860A5049228092 @default.
- W4313404860 hasAuthorship W4313404860A5056955604 @default.
- W4313404860 hasAuthorship W4313404860A5057849939 @default.
- W4313404860 hasAuthorship W4313404860A5076121567 @default.
- W4313404860 hasConcept C136449434 @default.
- W4313404860 hasConcept C147483822 @default.
- W4313404860 hasConcept C185592680 @default.
- W4313404860 hasConcept C203014093 @default.
- W4313404860 hasConcept C2780868878 @default.
- W4313404860 hasConcept C2781236682 @default.
- W4313404860 hasConcept C86803240 @default.
- W4313404860 hasConcept C8891405 @default.
- W4313404860 hasConcept C95444343 @default.
- W4313404860 hasConceptScore W4313404860C136449434 @default.
- W4313404860 hasConceptScore W4313404860C147483822 @default.
- W4313404860 hasConceptScore W4313404860C185592680 @default.
- W4313404860 hasConceptScore W4313404860C203014093 @default.
- W4313404860 hasConceptScore W4313404860C2780868878 @default.
- W4313404860 hasConceptScore W4313404860C2781236682 @default.
- W4313404860 hasConceptScore W4313404860C86803240 @default.
- W4313404860 hasConceptScore W4313404860C8891405 @default.
- W4313404860 hasConceptScore W4313404860C95444343 @default.
- W4313404860 hasIssue "1_Supplement" @default.
- W4313404860 hasLocation W43134048601 @default.
- W4313404860 hasOpenAccess W4313404860 @default.
- W4313404860 hasPrimaryLocation W43134048601 @default.
- W4313404860 hasRelatedWork W1481917790 @default.
- W4313404860 hasRelatedWork W1519040467 @default.
- W4313404860 hasRelatedWork W1914689199 @default.
- W4313404860 hasRelatedWork W1974103061 @default.
- W4313404860 hasRelatedWork W2103675344 @default.
- W4313404860 hasRelatedWork W2141330728 @default.
- W4313404860 hasRelatedWork W2220102944 @default.
- W4313404860 hasRelatedWork W2409441623 @default.
- W4313404860 hasRelatedWork W2888060141 @default.
- W4313404860 hasRelatedWork W4210976760 @default.
- W4313404860 hasVolume "208" @default.
- W4313404860 isParatext "false" @default.
- W4313404860 isRetracted "false" @default.
- W4313404860 workType "article" @default.